Gilead to pay $97 million to settle U.S. kickback probe

WASHINGTON (Reuters) – Gilead Sciences Inc has agreed to pay $97 million to resolve U.S. government claims it used a purportedly independent charity to pay illegal kickbacks to cover Medicare patients’ out-of-pocket costs for its pulmonary arterial hypertension drug Letairis.FILE

Nasdaq, S&P 500 crawl higher on Amazon, Apple boost

(Reuters) – The S&P 500 and the Nasdaq edged higher on Tuesday, led by a bounce in shares of Amazon.com and Apple, while uncertainty over more U.S. fiscal stimulus kept trading in Dow constituents muted.The U.S. flag is seen outside

Indexes drop more than 1% as tech sell-off continues

(Reuters) – Major U.S. stock indexes were down more than 1% in afternoon trading as technology shares sold off again and investors kept worrying about rising coronavirus cases.FILE PHOTO: Health care workers walk with protective face masks on past the

Wall Street ends lower as tech struggles resume

NEW YORK (Reuters) – U.S. stocks closed lower after a choppy trading session on Thursday as heavyweight tech-related stocks resumed their decline following a sharp rebound the previous session, while elevated jobless claims reminded investors of a still-difficult recovery ahead.

Wall Street bounces as tech rout halts

(Reuters) – Wall Street’s main indexes jumped on Wednesday as investors took advantage of a three-day sell-off to buy cheaper technology-related stocks, a day after the Nasdaq confirmed correction territory. Tesla Inc shares jumped 6.9% after losing about a fifth

Nasdaq futures fall 2% as tech sell-off resumes

(Reuters) – Futures tracking the Nasdaq 100 index NQcv1 fell 2% on Monday, on the first full trading day after a report said SoftBank made significant option purchases during a Wall Street rally since a coronavirus-driven crash in March. SoftBank

Tech rout deepens, Nasdaq set for worst two-day fall since March

NEW YORK (Reuters) – The Nasdaq was on track for its worst two-day fall since mid-March on Friday as investors dumped heavyweight technology stocks, while concerns around a patchy economic recovery also hit the S&P 500 and the blue-chip Dow.